Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

EyePoint Pharmaceuticals Inc. buy Chardan Capital

EyePoint Pharmaceuticals Inc.
Start price
€11.30
03.08.23 / 50%
Target price
€20.11
03.08.24
Performance (%)
-37.17%
End price
€7.10
04.08.24
Summary
This prediction ended on 04.08.24 with a price of €7.10. Massive losses of -37.17% were the result for the BUY prediction by Chardan_Capital. Chardan_Capital has a follow-up prediction for EyePoint Pharmaceuticals Inc. where he still thinks EyePoint Pharmaceuticals Inc. is a Buy. Chardan_Capital has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
EyePoint Pharmaceuticals Inc. 6.955% 6.955% 77.699%
iShares Core DAX® -0,82 % -2,03 % 9,73 %
iShares Nasdaq 100 -1,74 % -5,35 % -0,86 %
iShares Nikkei 225® 1,21 % 6,38 % 27,79 %
iShares S&P 500 -1,17 % -3,46 % 0,10 %

Comments by Chardan_Capital for this prediction

In the thread EyePoint Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -37.17%
Target price 20.108
Change
Ends at 03.08.24

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $22.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat

Chardan Capital 
0
Report Share
03.08.23
In the thread Trading EyePoint Pharmaceuticals Inc.
Prediction Buy
Perf. (%) -37.17%
Target price 20.108
Change
Ends at 03.08.24

Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten

Chardan Capital 
0
Report Share
04.08.24

Current prediction by Chardan_Capital for EyePoint Pharmaceuticals Inc.

buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€6.23
06.03.25
€30.59
06.03.26
77.98%
16.02.26

Chardan Capital 
06.03.25 50%

Stopped prediction by Chardan_Capital for EyePoint Pharmaceuticals Inc.

buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.77
07.08.25
€23.15
07.08.26
26.48%
16.02.26

Chardan Capital 
07.08.25 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.43
08.05.25
€23.84
08.05.26
101.62%
16.02.26

Chardan Capital 
08.05.25 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€6.36
06.02.25
€31.85
06.02.26
83.31%
07.02.26

Chardan Capital 
06.02.25 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.87
08.11.24
€30.77
08.11.25
-12.71%
09.11.25

Chardan Capital 
08.11.24 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.28
29.10.24
€25.95
29.10.25
0.68%
30.10.25

Chardan Capital 
29.10.24 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.25
28.06.24
€26.15
28.06.25
-1.07%
29.06.25

Chardan Capital 
28.06.24 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€9.92
07.05.24
€25.98
07.05.25
-45.28%
08.05.25

Chardan Capital 
07.05.24 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.92
03.03.23
€19.79
03.03.24
797.26%
04.03.24

Chardan Capital 
03.03.23 50%